Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04728451 · ClinicalTrials.gov registry record · NA
Spectacle Prescribing in Early Childhood
A NA study of Astigmatism Bilateral and Eyeglasses, sponsored by University of Arizona.
- Active
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04728451 is a NA study of Astigmatism Bilateral and Eyeglasses that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04728451, a NA study of Astigmatism Bilateral and Eyeglasses, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare developmental outcome for young children (12 to 35 months of age) with astigmatism meeting American Academy of Ophthalmology spectacle prescribing guidelines and who are prescribed and provided spectacles for either Full-Time wear (encouraged and reinforced) or Ad Lib wear (wear dependent on child acceptance).
Conditions Studied
Interventions
- BEHAVIORAL Spectacle wear support
- DEVICE Spectacles
Study Locations (1)
Arizona
- The University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2027-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04728451
The ClinicalTrials.gov registry entry for NCT04728451 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Astigmatism Bilateral appearing as the primary indexed condition, and to 2 interventions - of which Spectacle wear support is the first listed.
NCT04728451 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04728451 about?
NCT04728451 is a clinical study titled "Spectacle Prescribing in Early Childhood". The purpose of this study is to compare developmental outcome for young children (12 to 35 months of age) with astigmatism meeting American Academy of Ophthalmology spectacle prescribing guidelines and who are prescribed and provided spectacles for either Full-Time wear (encouraged and reinforced) o...
What is the current status of trial NCT04728451?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2021-03-25. Estimated completion is 2027-02.
What conditions does trial NCT04728451 study?
This clinical trial studies the following conditions: Astigmatism Bilateral, Eyeglasses.
What interventions are being tested in trial NCT04728451?
The interventions under investigation include: Spectacle wear support (BEHAVIORAL), Spectacles (DEVICE).
Who is sponsoring clinical trial NCT04728451?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04728451 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.